Browse > Article
http://dx.doi.org/10.4062/biomolther.2007.15.2.102

Effect of Cimetidine on the Transport of Quinolone Antibiotics in Caco-2 Cell monolayers  

Kim, Seon-Hwa (Drug MetabolismTeam, Department of Pharmacology, National Institute of Toxicological Research)
Jung, Seo-Jeong (Center for Food & Drug Anaylsis, Busan KFDA)
Um, So-Young (Drug MetabolismTeam, Department of Pharmacology, National Institute of Toxicological Research)
Na, Mi-Ae (Testing & Analysis Team, Daejeon KFDA)
Choi, Min-Jin (Drug MetabolismTeam, Department of Pharmacology, National Institute of Toxicological Research)
Chung, Myeon-Woo (Drug MetabolismTeam, Department of Pharmacology, National Institute of Toxicological Research)
Oh, Hye-Young (Drug MetabolismTeam, Department of Pharmacology, National Institute of Toxicological Research)
Publication Information
Biomolecules & Therapeutics / v.15, no.2, 2007 , pp. 102-107 More about this Journal
Abstract
Cimetidine, a substrate for P-glycoprotein (P-gp), is a well known drug interacting with a variety of drugs and results in alteration of pharmacokinetic parameters by concomitant administration. The aim of present study was to investigate whether cimetidine affects the transport of various quinolone antibiotics in human colorectal cancer cell line (Caco-2) system which has been typically used to investigate drug transport via P-gp. The apparent permeability coefficients (P$_{app}$) value of 9 quinolone antibiotics in the co-treatment with cimetidine was examined. Apical to basolateral (AP-to-BL) transport of fleroxacin in the co-treatment with cimetidine was increased to 1.5-fold (p<0.01) compared with that of fleroxacin alone, whereas basolateral to apical (BL-to-AP) transport of fleroxacin was decreased to 0.83-fold significantly (p<0.05). Ofloxacin was decreased to 0.8-fold (p<0.01) and 0.72-fold (p<0.01) significantly in AP-to-BL and BL-to-AP direction, respectively by cimetidine cotreatment. The P$_{app}$ values of gatifloxacin, moxifloxacin, ciprofloxacin and rufloxacin also were changed by cimetidine. These results have a potential that cimetidine influences on the pharmacokinetics of quinolone antibiotics. It suggests that careful drug monitoring and dosage adjustment may be necessary during the co-administration of quinolone antibiotics with cimetidine.
Keywords
Cimetidine; P-glycoprotein; Quinolone antibiotics; Caco-2; Apparent permeability coefficients;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Guidance for Industry. Waiver of in vivo Bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. CDER, FDA, August, 2000
2 Artursson P., Karlsson J. (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175, pp. 880-885   DOI   ScienceOn
3 Ayrton A., Morgan P. (2001) Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica. 31, pp. 469-497   DOI
4 Chetan S. Karyekar, M.D., Ph.D., Natalie D. Eddington, Ph.D., Tushar S. Garimella, M.S., Paul O. Gubbins, Pharm.D., Thomas C. Dowling, Pharm.D., Ph.D. (2004) Evaluation of P-glycoprotein-Mediated Renal Drug Interactions in an MDR1-MDCK Model. Pharmacother. 23(4), pp. 436-442   DOI   ScienceOn
5 Foote E.F. and Halstenson C.E. (1998) Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats, Antimicrob. Agents Cehmother. 42, pp. 456-458
6 Gan L.S., Hsyu P.H., Pritchard J.F., Thakker D. (1993) Mechanism of intestinal absorption of ranitidine and ondansetron: Transport across Caco-2 monolayers. Pharm. Res. 10, pp. 1722-1725   DOI
7 Hunter J., Jepson M.A., Tsuruo T., Simmons N.L., Hirst B.H. (1993) Functional expression of P-glycoprotein in apical membranes of human intestinal Caco-2 cells. Kinetics of vinblastine secretion and interaction with modulators. J. Biol. Chem. 268, pp. 14991-14997
8 Jaehde U., Sorgel F., Stephan U., Schunack W. (1994) Effect of an antacid containing magnesium and aluminum on absorption, metabolism, and mechanism of renal elimination of pefloxacin in humans. Antimicrob. Agents Cehmother. 38, pp. 1129-1133   DOI   ScienceOn
9 Juliano RL, Ling V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 455, pp. 152-162   DOI   ScienceOn
10 Jung S.J., Choi S.O., Um S.Y., Kim J.I., Choo H.Y., Choi S.Y., Chung S.Y. (2006) Prediction of the permeability of drugs through study on quantitative structure-permeability relationship. J. Pharm. Biomed. Anal. 41, pp. 469-475   DOI   ScienceOn
11 Kartner N., Riodan J.R., Ling V. (1983) Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 221, pp. 1285-1288   DOI
12 Balayssac D., Authier N, Cayre A. Coudore F. (2005) Does inhibition of P-glycoprotein lead to drug-drug interactions? Toxicol Lett. 156, pp. 319-329   DOI   ScienceOn
13 Behrens I., Kissel T. (2003) Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers? Eur J Pharm Sci. 19, pp. 433-442   DOI   ScienceOn
14 Gottesman, M.M., Pastan I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, pp. 385-427   DOI   ScienceOn
15 Collett A., Higgs N. B., Sims E., Rowland M., Warhurst G. (1998) Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colone cell line Caco-2. J. Pharmacol. Exp. Ther., 288, pp. 171-178
16 Geisen P., McColm J.R., King B.M., Hartnett M.E. (2006) Characterization of barrier properties and inducible VEGF expression of several types of retinal pigment epithelium in mediumterm culture. Curr Eye Res. 31, pp. 739-748   DOI   ScienceOn
17 Germann U.A., Pastan I., Gottesman M.M. (1993) P-glycoproteins: Mediators of multidrug resistance. Semin. Cell Bil. 4, pp. 63-76   DOI   ScienceOn
18 Hosoya K.I., Kim K.J., Lee V.H. (1996) Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharm. Res. 13, pp. 885-890   DOI
19 Karyekar C.S., Eddington N.D., Briglia A., Gubbins P.O., Dowling T.C. (2004) Renal interaction between itraconazole and cimetidine. J. Clin. Pharmacol. 44, pp. 919-927   DOI
20 Klingberg T.D, Pedersen M.H., Cencic A., Budde B.B. (2005) Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity. Appl Environ Microbiol. 71, pp. 7528-7530   DOI   ScienceOn
21 Kolawole J.A., Mustapha A., Abudu-Aguye I., Ochekpe N. (2000) Mefloquine pharmacokinetics in healthy subjects and in peptic ulcer patients after cimetidine administration. Eur J Drug Metab Pharmacokinet. 25, pp. 165-170   DOI   ScienceOn
22 Neu H.C. (1992) Quinolone antimicrobial agents. Annu. Rev. Med. 43, pp. 465-486   DOI   ScienceOn
23 Kosoglou T., Salfi M., Lim J.M., Batra V.K., Cayen M.N., Affrime M.B. (2000) Evaluation of the pharmacokinetics and electrocardiographic pharmacodynamics of loratadine with concomitant administration of ketoconazole or cimetidine. Br J Clin Pharmacol. 50, pp. 581-589   DOI
24 Lazzaroni M, Imbimbo B.P., Bargiggia S., Sangaletti O., Dal Bo L., Broccali G., Bianchi Porro G.. (1993) Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin. Antimicrob. Agents Chemother. 37, pp. 2212-2216   DOI   ScienceOn
25 Narumi S., Kumiko T., Akihiro M., Kenji A., Hiroshi T., Koji F. (2006) Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer. Toxicology 23, pp. 156-165
26 Rubas W., Jezuk N., Grass G.M. (1993) Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharm. Res. 10, pp.113-118   DOI
27 Schinked, A.H., Mayer U., Wagenaar E., Mol C.A., van Deemter L. Smit J.J, van der Valk M.A., Voordouw A.C., Spits H., van Tellingen O., Zijlmans J.M., Fibbe W.E., Borst P. (1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Nat., Acad. Sci. 94, pp. 4028-4033   DOI   ScienceOn
28 Shimada J., Shiba K., Oguma T., Miwa H., Yoshimura Y., Nishikawa T., Okabayashi Y., Kitagawa T., Yamamoto S. (1992) Effect of antacid on absorption of the quinolone lomefloxacin. Antamicrob. Agents Chemother. 36, pp. 1219-1224   DOI   ScienceOn
29 Weidekamm E., Portmann R., Suter K., Partos C., Dell D., Lucker P.W. (1987) Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinate quinolone, in humans. Antimicrob. Agents Chemother. 31, pp. 1909-1914   DOI   ScienceOn
30 Suzuki H., Sugiyama Y. (2000) Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur J Pharm Sci. 12, pp. 3-12   DOI   ScienceOn
31 Wise R. (1984) Norfloxacin, a review of pharmacology and tissue penetration. J. Antimicrobiol. Chemother. 13, pp. 59-64
32 Pan B.H., Dutt A., Nelson A. (1994) Enhanced transepithelial flux of cimetidine by Madin-Darby Canine Kidney cells overexpressing human P-glycoprotein. J. Pharmacol. Exp. Ther., 270, pp. 1-7
33 Pedersen K.E., Chrstiansen B.D., Klitgaard N.A., Nielsen-Kudsk, F. (1983) Effect of quinidine on dioxin bioavailability. Eur. J. Clin. Pharmacol. 24, pp. 41-47   DOI